EU Pharma Rejects Proposed Changes To Orphan Medicine Criteria

Companies Want More Incentives For New Drug Development

 
• By Ian Schofield
  
3D illustration of REVISION script on road sign
The EU pediatric and orphan drug legislation is being revised. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography